Packaging | September 22, 2021
SCHOTT expands tubing capacity in India
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT
This facility will integrate with existing Max hospitals and create a 2,300-bed contiguous medical hub spread over 23 acres. The first phase is to be ready by 2024
It strengthens Syngene’s portfolio as a fully integrated custom biomanufacturer with added mammalian and microbial capabilities for clinical and commercial supplies
This investment is being made to set up a high speed 400 vials a minute injectable fill line with isolator technology
We focused on developing the product last year but now our focus is on ramping up our manufacturing capacity
The country has constantly worked with the spirit of public-private partnership
This follows a $6 million expansion in Rosenberg in 2025 and signals a major push to boost commercial capacity, expand R&D capabilities, and meet rising demand for US-based drug product manufacturing
The Clear Lake facility marks Clariant’s first U.S. site dedicated to PEG excipient production
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The facility features 2,176 high-performance GPUs across the US and Europe
Subscribe To Our Newsletter & Stay Updated
